Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × cixutumumab × Clear all

NCT01026623 2019-06-17

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Phase 1/2 Completed

16 enrolled 12 charts

Prostatic Neoplasms